INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

Estimated average burden
OMB Number:			3235-0104
hours per response:			0.5

1. Name and Address of Reporting Person^*

Crandall Ryan

(Last)

(First)

(Middle)

10 OCEANA WAY, 2ND FLOOR

(Street)

NORWOOD

02062

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
04/07/2025

3. Issuer Name and Ticker or Trading Symbol
MARIMED INC. [ MRMD ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Chief Commercial Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

**Table I - Non-Derivative Securities Beneficially Owned**
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock, par value $.001 per share	598,002	D

**Table II - Derivative Securities Beneficially Owned**
**(e.g., puts, calls, warrants, options, convertible securities)**
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Restricted Stock Units (RSU)	⁽¹⁾	⁽¹⁾	Common Stock, par value $.001 per share	225,000	0⁽²⁾	D
Restricted Stock Units (RSU)	⁽³⁾	⁽³⁾	Common Stock, par value $.001 per share	24,189	0⁽²⁾	D
Restricted Stock Units (RSU)	⁽⁴⁾	⁽⁴⁾	Common Stock, par value $.001 per share	162,000	0⁽²⁾	D
Restricted Stock Units (RSU)	⁽⁵⁾	⁽⁵⁾	Common Stock, par value $.001 per share	25,000	0⁽²⁾	D
Option to buy common stock	⁽⁶⁾	12/23/2026	Common Stock, par value $.001 per share	1,000,000	0.76	D
Option to buy common stock	⁽⁶⁾	11/11/2025	Common Stock, par value $.001 per share	1,000,000	0.25	D

Explanation of Responses:

1. The RSUs vest over a three-year period as follows: (i) one-third on November 29, 2025; and (ii) in equal one-sixth installments every six months following November 29, 2025 through November 29, 2027, in accordance with the terms of an award agreement between the Issuer and the Reporting Person.

2. RSUs convert to shares of common stock on a one-for-one basis.

3. The RSUs vest in equal one-fourth installments every six months beginning on September 28, 2025 through March 28, 2027, in accordance with the terms of an award agreement between the Issuer and the Reporting Person.

4. The RSUs vest in three equal installments of 54,000 shares of common stock on each of June 8, 2025, December 8, 2025 and June 8, 2026, respectively, in accordance with the terms of an award agreement between the Issuer and the Reporting Person.

5. The RSUs vest in two equal installments of 12,500 shares of common stock on each of September 7, 2025 and March 7, 2026, in accordance with the terms of an award agreement between the Issuer and the Reporting Person.

6. Immediately.

Remarks:

	/s/ Ryan Crandall	04/11/2025
	** Signature of Reporting Person	Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.